Evidence map›Paper›PMID 27322232›Full record

ArticleMolecules (Basel, Switzerland)2016

Anti-Inflammatory Effects of Agrimoniin-Enriched Fractions of Potentilla erecta.

Julia Hoffmann, Federica Casetti, Ute Bullerkotte, Birgit Haarhaus, Jan Vagedes, Christoph M Schempp, Ute Wölfle

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 37 citations in OpenAlex.

  1. Unlocking Potential ofGels (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Optimisation of Phenolic Compound Extraction fromAntioxidants (Basel, Switzerland) · 2025
    Article
  5. Review
  6. Harnessing the Power ofMolecules (Basel, Switzerland) · 2025
    Review
  7. Review
  8. International journal of molecular sciences · 2024
    Article
  9. Phytochemical Profiling of Extracts from RareInternational journal of molecular sciences · 2023
    Article
  10. Review
  11. The Anti-Inflammatory Effect ofPharmaceuticals (Basel, Switzerland) · 2022
    Article
  12. Article
  13. Study of the Antimicrobial Activity of the Chinese Dong Ethnic Minority Medicine, Madeng'ai.Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
  14. Article
  15. Article
  16. Preventive Applications of Polyphenols in Dentistry-A Review.International journal of molecular sciences · 2021
    Review
  17. Article
  18. Article
  19. Phenolic, Antioxidant, Antimicrobial, andIranian journal of pharmaceutical research : IJPR · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Julia HoffmannDepartment of Dermatology, University Medical Center, 79104 Freiburg, Germany. julia.hoffmann@uniklinik-freiburg.de.
Federica CasettiDepartment of Dermatology, University Medical Center, 79104 Freiburg, Germany. usfreiburg@gmx.de.
Ute BullerkotteDepartment of Dermatology, University Medical Center, 79104 Freiburg, Germany. birgit.haarhaus@uniklinik-freiburg.de.
Birgit HaarhausDepartment of Dermatology, University Medical Center, 79104 Freiburg, Germany. christoph.schempp@uniklinik-freiburg.de.
Jan VagedesARCIM Institute, 70794 Filderstadt-Bonlanden, Germany. j.vagedes@arcim-institute.de.
Christoph M SchemppDepartment of Dermatology, University Medical Center, 79104 Freiburg, Germany.
Ute WölfleDepartment of Dermatology, University Medical Center, 79104 Freiburg, Germany. ute.woelfle@uniklinik-freiburg.de.
University Medical Center Freiburg · DEAcademic Research in Complementary and Integrative Medicine · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Potentilla erecta (PE) is a small herbaceous plant with four yellow petals belonging to the Rosaceae family. The rhizome of PE has traditionally been used as an antidiarrheal, hemostatic and antihemorrhoidal remedy. PE contains up to 20% tannins and 5% ellagitannins, mainly agrimoniin. Agrimoniin is a hydrolyzable tannin that is a potent radical scavenger. In this study we tested the anti-inflammatory effect of four PE fractions with increasing amounts of agrimoniin obtained by Sephadex column separation. First, we analyzed in HaCaT keratinocytes the expression of cyclooxygenase-2 (COX-2) induced by ultraviolet-B (UVB) irradiation. As COX-2 catalyzes the metabolism of arachidonic acid to prostanoids such as PGE₂, we also measured the PGE₂ concentration in cell culture supernatants. PE inhibited UVB-induced COX-2 expression in HaCaT cells and dose-dependently reduced PGE₂. The PE fraction with the highest agrimoniin amount (PE4) was the most effective in this experiment, whereas fraction PE1 containing mainly sugars had no effect. PE4 also dose dependently inhibited the phosphorylation of the epidermal growth factor receptor (EGFR) which plays a crucial role in UVB-mediated COX-2 upregulation. A placebo-controlled UV-erythema study with increasing concentrations of PE4 demonstrated a dose dependent inhibition of UVB-induced inflammation in vivo. Similarly, PE4 significantly reduced UVB-induced PGE₂ production in suction blister fluid in vivo. In summary, PE fractions with a high agrimoniin content display anti-inflammatory effects in vitro and in vivo in models of UVB-induced inflammation.

Indexed as

Anti-Inflammatory AgentsCyclooxygenase 2ErbB ReceptorsGene Expression RegulationHydrolyzable TanninsInflammationKeratinocytesPlant ExtractsPotentillaRhizomeUltraviolet RaysagrimoniinAnti-Inflammatory AgentsCyclooxygenase 2EGFR protein, humanErbB ReceptorsHydrolyzable TanninsPlant ExtractsPTGS2 protein, humanagrimoniinCOX-2EGFRPGE2Potentilla erectaUVB

Identifiers

PMID27322232
PMCPMC6273098
OpenAlexW2431345429

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.